Qiagen N.V. (NYSE: QGEN) has announced two strategic partnerships designed to revolutionize minimal residual disease (MRD) ...

QIAGEN expands its oncology diagnostics with partnerships advancing minimal residual disease testing for solid tumors & blood ...

The deals cover development and commercialization of next-generation sequencing and digital PCR assays for minimal residual disease detection.

Two new partnerships enhance QIAGEN’s capabilities to support pharma partner clinical trials with significant expansion of ...

Foresight Diagnostics, a leading diagnostics company specializing in ultra-sensitive minimal residual disease (MRD) detection, today announced a strategic, worldwide partnership with QIAGEN (NYSE: ...

Eluates from the Zymo kits also tested positive for DNA in fluorescent intercalator dye and whole genome amplification (WGA) assays. Qiagen kits tested positive in the fluorescence assay but negative ...

Qiagen (NYSE:QGEN) announced a new commercial collaboration and joint marketing agreement with French company ID Solutions to ...

Qiagen has entered into a commercial collaboration with ID Solutions for digital polymerase chain reaction (dPCR) assays.

Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform ...

Coronation Street fans were quick to voice their reactions on Friday night as Kit Green's past was laid bare. In the latest episode, viewers were given a glimpse into Kit's childhood and history ...

PAUL FLAHIVE, BYLINE: The Houston Forensic Science Center is reviewing hundreds of cases after it detected problems with Qiagen EZ1&2 Investigator DNA test kits. Center CEO Peter Stout says tests ...